Do prostate-specific antigen parameters have a similar role in predicting prostate cancer regardless of serum testosterone levels in men with gray-zone prostate-specific antigen levels?

Oh, Jeong Hoon; Chung, Ho Seok; Kim, Myung Soo; Hwang, Eu Chang; Jung, Seung Il; Kwon, Dongdeuk; Park, Kwangsung

Oh, Jeong Hoon; Chung, Ho Seok; Kim, Myung Soo; Hwang, Eu Chang; Jung, Seung Il; Kwon, Dongdeuk; Park, Kwangsung.

Afiliación

Oh JH; Department of Urology, Chonnam National University Medical School, Gwangju, Republic of Korea.
Chung HS; Department of Urology, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea.
Kim MS; Department of Urology, Ewha Womans University, College of Medicine, Seoul, Republic of Korea.
Hwang EC; Department of Urology, Chonnam National University Medical School, Gwangju, Republic of Korea.
Jung SI; Department of Urology, Chonnam National University Medical School, Gwangju, Republic of Korea.
Kwon D; Department of Urology, Chonnam National University Medical School, Gwangju, Republic of Korea.
Park K; Department of Urology, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea.

Transl Androl Urol ; 11(4): 421-429, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35558261

Palabras clave

Prostate-specific antigen (PSA); prostatic neoplasms; testosterone

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Androl Urol Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google